• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Transplant of a Kidney from a Hepatitis C Viremic Donor to a Naïve Recipient without Viral Transmission: A Case Report.从丙型肝炎病毒血症供体向无病毒传播的受体移植肾脏:一例报告。
Am J Case Rep. 2021 May 6;22:e927532. doi: 10.12659/AJCR.927532.
2
Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool.利用 HCV Ab+/NAT- 供体进行 HCV 初治肾移植受者以扩大肾脏供体池。
Clin Transplant. 2019 Jul;33(7):e13598. doi: 10.1111/ctr.13598. Epub 2019 Jun 5.
3
Hepatitis C Virus NAT-Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus-Negative Recipients: A Real-World Experience.丙型肝炎病毒核酸检测阳性的实体器官移植物移植到丙型肝炎病毒阴性受者:真实世界的经验。
Hepatology. 2020 Jul;72(1):32-41. doi: 10.1002/hep.31011. Epub 2020 Apr 15.
4
Renal transplantation from seropositive hepatitis C virus donors to seronegative recipients in Spain: a prospective study.西班牙对 HCV 血清阳性供者向 HCV 血清阴性受者进行肾移植:一项前瞻性研究。
Transpl Int. 2019 Jul;32(7):710-716. doi: 10.1111/tri.13410. Epub 2019 Mar 10.
5
Factors associated with hepatitis C antibody seroconversion after transplantation of kidneys from hepatitis C infected donors to hepatitis C naïve recipients.丙型肝炎感染供体的肾脏移植给未感染丙型肝炎的受体后,与丙型肝炎抗体血清转化相关的因素。
Ren Fail. 2020 Nov;42(1):767-775. doi: 10.1080/0886022X.2020.1798784.
6
Expanding the Deceased Donor Pool in Manitoba Using Hepatitis C-Viremic Donors: Program Report.利用丙型肝炎病毒血症供体扩大曼尼托巴省已故供体库:项目报告
Can J Kidney Health Dis. 2021 Jul 26;8:20543581211033496. doi: 10.1177/20543581211033496. eCollection 2021.
7
Hepatitis C virus (HCV) RNA level in plasma and kidney tissue in HCV antibody-positive donors: Quantitative comparison.血浆和 HCV 抗体阳性供体肾组织中的丙型肝炎病毒(HCV)RNA 水平:定量比较。
Clin Transplant. 2018 Sep;32(9):e13358. doi: 10.1111/ctr.13358. Epub 2018 Sep 10.
8
Transplantation of hepatitis C virus (HCV) antibody positive, nucleic acid test negative donor kidneys to HCV negative patients frequently results in seroconversion but not HCV viremia.将丙型肝炎病毒 (HCV) 抗体阳性、核酸检测阴性的供体肾脏移植给 HCV 阴性患者,常导致血清转换,但不会引起 HCV 病毒血症。
Am J Transplant. 2018 Oct;18(10):2451-2456. doi: 10.1111/ajt.15031. Epub 2018 Aug 27.
9
Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients.丙型肝炎病毒血清阳性、无病毒血症供者向非丙型肝炎肝移植受者的传播。
Hepatology. 2018 May;67(5):1673-1682. doi: 10.1002/hep.29704. Epub 2018 Mar 26.
10
Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens.成功治疗来自一名血源性病原体感染风险增加的供体的三名移植受者的供体源性丙型肝炎病毒感染。
Transpl Infect Dis. 2017 Apr;19(2). doi: 10.1111/tid.12660. Epub 2017 Feb 22.

本文引用的文献

1
Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients.将来自丙型肝炎病毒血症供体的肾脏移植给丙型肝炎病毒阴性受体后,基于索磷布韦的抗病毒治疗早期成功。
Transpl Infect Dis. 2019 Oct;21(5):e13146. doi: 10.1111/tid.13146. Epub 2019 Jul 31.
2
Transplantation of kidneys from hepatitis C-infected donors to hepatitis C-negative recipients: Single center experience.从丙型肝炎感染供体向丙型肝炎阴性受者移植肾脏:单中心经验。
Am J Transplant. 2019 Nov;19(11):3046-3057. doi: 10.1111/ajt.15530. Epub 2019 Aug 2.
3
Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool.利用 HCV Ab+/NAT- 供体进行 HCV 初治肾移植受者以扩大肾脏供体池。
Clin Transplant. 2019 Jul;33(7):e13598. doi: 10.1111/ctr.13598. Epub 2019 Jun 5.
4
Transplantation of hepatitis C virus (HCV) antibody positive, nucleic acid test negative donor kidneys to HCV negative patients frequently results in seroconversion but not HCV viremia.将丙型肝炎病毒 (HCV) 抗体阳性、核酸检测阴性的供体肾脏移植给 HCV 阴性患者,常导致血清转换,但不会引起 HCV 病毒血症。
Am J Transplant. 2018 Oct;18(10):2451-2456. doi: 10.1111/ajt.15031. Epub 2018 Aug 27.
5
Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial.直接作用抗病毒预防在丙型肝炎病毒感染供体向非感染受者的肾移植中的应用:一项开放标签非随机试验。
Ann Intern Med. 2018 Apr 17;168(8):533-540. doi: 10.7326/M17-2871. Epub 2018 Mar 6.
6
Transplantation of Renal Allografts From Organ Donors Reactive for HCV Antibodies to HCV-Negative Recipients: Safety and Clinical Outcome.将丙型肝炎病毒(HCV)抗体反应性器官捐献者的同种异体肾移植给HCV阴性受者:安全性和临床结果
Kidney Int Rep. 2016 Oct 6;2(1):53-59. doi: 10.1016/j.ekir.2016.09.058. eCollection 2017 Jan.
7
Utilization of Organs From Donors According to Hepatitis C Antibody and Nucleic Acid Testing Status: Time for Change.根据丙型肝炎抗体和核酸检测结果利用供者器官:是时候改变了。
Am J Transplant. 2017 Nov;17(11):2863-2868. doi: 10.1111/ajt.14386. Epub 2017 Jul 8.
8
The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation.美国移植学会关于在实体器官移植中使用丙型肝炎病毒血症供体的共识会议。
Am J Transplant. 2017 Nov;17(11):2790-2802. doi: 10.1111/ajt.14381. Epub 2017 Jul 1.
9
Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients.将丙型肝炎病毒感染的肾脏移植给未感染受者的试验。
N Engl J Med. 2017 Jun 15;376(24):2394-2395. doi: 10.1056/NEJMc1705221. Epub 2017 Apr 30.
10
Seroconversion rates among health care workers exposed to hepatitis C virus-contaminated body fluids: The University of Pittsburgh 13-year experience.医务人员接触丙型肝炎病毒污染体液后的血清转换率:匹兹堡大学 13 年的经验。
Am J Infect Control. 2017 Sep 1;45(9):1001-1005. doi: 10.1016/j.ajic.2017.03.011. Epub 2017 Apr 24.

从丙型肝炎病毒血症供体向无病毒传播的受体移植肾脏:一例报告。

Transplant of a Kidney from a Hepatitis C Viremic Donor to a Naïve Recipient without Viral Transmission: A Case Report.

机构信息

Division of Transplant Surgery, University of Virginia, Charlottesville, VA, USA.

出版信息

Am J Case Rep. 2021 May 6;22:e927532. doi: 10.12659/AJCR.927532.

DOI:10.12659/AJCR.927532
PMID:33953151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8112284/
Abstract

BACKGROUND Kidneys from deceased donors who were positive for hepatitis C virus (HCV) on a nucleic acid amplification test (NAT) are not given to anti-HCV antibody-negative recipients. This is because of the high risk of HCV transmission, combined with the lack of effective antiviral treatment. Several studies have demonstrated rates of transmission of HCV from anti-HCV-positive/HCV NAT-positive donors to anti-HCV-negative recipients of 100%. Ours is the first report of transplantation of a kidney from an anti-HCV antibody-positive/HCV NAT-positive donor into an anti-HCV antibody-negative recipient who remains anti-HCV antibody-negative at 3 months after transplant with no treatment. CASE REPORT A 49-year-old man had a history of end-stage renal disease that was presumed to be secondary to type ll diabetes. He received a kidney from a deceased donor who was HCV antibody-positive/NAT-negative. The patient's HCV antibody status was checked prior to transplant and he was found to be negative and nonreactive. Since the transplant, his HCV viral load has been checked 5 times, on postoperative days 15, 23, 44, 62, and 64; each time, it has been undetectable. Furthermore, the patient's HCV antibody status was rechecked 1 month after transplant and it remained negative and nonreactive. CONCLUSIONS Further research is required on the accuracy of polymerase chain reaction as an indicator of donor HCV infection when the quantity of the viral load is not reported.

摘要

背景

核酸扩增试验(NAT)检测到丙型肝炎病毒(HCV)阳性的已故供体的肾脏不会给予抗 HCV 抗体阴性的受者。这是因为 HCV 传播的风险很高,再加上缺乏有效的抗病毒治疗。几项研究表明,HCV 从抗 HCV 阳性/HCV NAT 阳性供体传播到抗 HCV 阴性受者的比率为 100%。我们的报告是首例将抗 HCV 抗体阳性/HCV NAT 阳性供体的肾脏移植到抗 HCV 抗体阴性受者体内的病例,该受者在移植后 3 个月未接受任何治疗,仍保持抗 HCV 抗体阴性。

病例报告

一名 49 岁男性患有终末期肾病,据推测是由 2 型糖尿病引起的。他接受了一名 HCV 抗体阳性/NAT 阴性的已故供体的肾脏。患者在移植前检查了 HCV 抗体状况,结果为阴性且无反应。自移植以来,他的 HCV 病毒载量已被检查了 5 次,分别在术后第 15、23、44、62 和 64 天;每次检测均为未检测到。此外,患者在移植后 1 个月再次检查 HCV 抗体状态,结果仍为阴性且无反应。

结论

当未报告病毒载量时,需要进一步研究聚合酶链反应作为供体 HCV 感染指标的准确性。